Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 366

2.

Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis.

Røpke MA, Alonso C, Jung S, Norsgaard H, Richter C, Darvin ME, Litman T, Vogt A, Lademann J, Blume-Peytavi U, Kottner J.

J Dermatol Sci. 2017 Dec;88(3):330-338. doi: 10.1016/j.jdermsci.2017.08.009. Epub 2017 Aug 26.

PMID:
28911799
3.

Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization.

Nadkarni A, Saleem MD, Feldman SR.

J Drugs Dermatol. 2017 Aug 1;16(8):755-758.

PMID:
28809990
4.

Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol.

Mokhtari F, Bostakian A, Shahmoradi Z, Jafari-Koshki T, Iraji F, Faghihi G, Hosseini SM, Bafandeh B.

J Cosmet Dermatol. 2018 Apr;17(2):165-170. doi: 10.1111/jocd.12373. Epub 2017 Jul 19.

PMID:
28722334
5.

The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis.

Rajabi-Estarabadi A, Hasanzadeh H, Taheri A, Feldman SR, Firooz A.

J Dermatolog Treat. 2018 Mar;29(2):111-115. doi: 10.1080/09546634.2017.1341616. Epub 2017 Jul 6.

PMID:
28609161
6.

Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis.

Saleem MD, Feldman SR.

J Dermatolog Treat. 2018 Feb;29(1):36-38. doi: 10.1080/09546634.2017.1329508. Epub 2017 May 31.

PMID:
28494626
7.

Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis.

Pariser D, Bukhalo M, Guenthner S, Kempers S, Shideler S, Gold LS, Tschen E, Berg J, Ferdon MB, Dromgoole S.

J Drugs Dermatol. 2017 Mar 1;16(3):234-240.

PMID:
28301619
8.
9.

Halobetasol Propionate Lotion, 0.05% Provides Superior Hydration Compared to Halobetasol Propionate Cream, 0.05% in a Double-Blinded Study of Occlusivity and Hydration.

Grove G, Zerweck C, Houser T, Andrasfay A, Gauthier B, Holland C, Piacquadio D.

J Drugs Dermatol. 2017 Feb 1;16(2):140-144.

PMID:
28300856
10.

Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.

Guttman-Yassky E, Ungar B, Malik K, Dickstein D, Suprun M, Estrada YD, Xu H, Peng X, Oliva M, Todd D, Labuda T, Suarez-Farinas M, Bissonnette R.

J Allergy Clin Immunol. 2017 Oct;140(4):1032-1042.e13. doi: 10.1016/j.jaci.2017.01.027. Epub 2017 Feb 24.

11.

A Randomized, Single-Blind Trial of Clobetasol Propionate 0.05% Cream Under Silicone Dressing Occlusion Versus Intra-Lesional Triamcinolone for Treatment of Keloid.

Nor NM, Ismail R, Jamil A, Shah SA, Imran FH.

Clin Drug Investig. 2017 Mar;37(3):295-301. doi: 10.1007/s40261-016-0484-x.

PMID:
27888448
12.

Comparison of topical tacrolimus and clobetasol in the management of symptomatic oral lichen planus: A double-blinded, randomized clinical trial in Sri Lanka.

Hettiarachchi PVKS, Hettiarachchi RM, Jayasinghe RD, Sitheeque M.

J Investig Clin Dent. 2017 Nov;8(4). doi: 10.1111/jicd.12237. Epub 2016 Sep 15.

PMID:
27633647
13.

Comparison of the efficacy of 308-nm excimer lamp monotherapy with topical tacrolimus or clobetasol 17-propionate combination therapies in localized vitiligo.

Bapur Erduran F, Adışen E.

Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):247-253. doi: 10.1111/phpp.12266. Epub 2016 Sep 27.

PMID:
27552312
14.

A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo.

Kanokrungsee S, Chanprapaph K, Chaiyabutr C, Vachiramon V.

Lasers Med Sci. 2016 Sep;31(7):1343-9. doi: 10.1007/s10103-016-1982-z. Epub 2016 Jun 13.

PMID:
27291387
15.

Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution.

Bodenlenz M, Dragatin C, Liebenberger L, Tschapeller B, Boulgaropoulos B, Augustin T, Raml R, Gatschelhofer C, Wagner N, Benkali K, Rony F, Pieber T, Sinner F.

Pharm Res. 2016 Sep;33(9):2229-38. doi: 10.1007/s11095-016-1960-y. Epub 2016 Jun 6.

16.

Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque Psoriasis: A Randomized Clinical Trial.

Kumar R, Dogra S, Amarji B, Singh B, Kumar S, Sharma, Vinay K, Mahajan R, Katare OP.

JAMA Dermatol. 2016 Jul 1;152(7):807-15. doi: 10.1001/jamadermatol.2016.0859.

PMID:
27096709
18.

Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.

Erlendsson AM, Karmisholt KE, Haak CS, Stender IM, Haedersdal M.

J Am Acad Dermatol. 2016 Apr;74(4):709-15. doi: 10.1016/j.jaad.2015.11.034. Epub 2016 Jan 22.

PMID:
26810403
19.

Comparison of 5-Aminolevulinic Acid Photodynamic Therapy and Clobetasol Propionate in Treatment of Vulvar Lichen Sclerosus.

Shi L, Miao F, Zhang LL, Zhang GL, Wang PR, Ji J, Wang XJ, Huang Z, Wang HW, Wang XL.

Acta Derm Venereol. 2016 Jun 15;96(5):684-8. doi: 10.2340/00015555-2341.

20.

Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial.

Wilken R, Li CS, Sharon VR, Kim K, Patel FB, Patel F, Maverakis E.

Trials. 2015 Aug 22;16:374. doi: 10.1186/s13063-015-0879-7.

Supplemental Content

Loading ...
Support Center